tirzepatide side effects for women You Should Know Before Starting Treatment Women's Tirzepatide Treatment in Spokane:

Unlike traditional GLP-1 receptor agonists, Retatrutide is a triple hormone receptor agonist, targeting: GLP-1 GIP Glucagon This unique mechanism has shown promising results in clinical trials, including: Significant weight loss Improved glycemic control in people with type 2 diabetes Better insulin sensitivity Potential improvements in cardiometabolic health and liver fat Once-weekly administration in clinical studies Its important to remember that Retatrutide is still an investigational medication and has not yet received regulatory approval for routine clinical use in many countries

I wouldnt call it muscle sparing

Common early side effects include mild nausea, reduced appetite, and occasional constipationmost resolve within 12 weeks as your body adapts